A ruling against skinny labeling could push back generic drug competition by years, with billions in costs passed on to ...

Supreme Court justices on Wednesday will hear arguments in a patent case that could change the way generic drug companies ...

In Canada, health regulators took one step to fill that gap by approving a generic version of semaglutide, which is the ...

Can a generic manufacturer compare its product to the branded competitor?

The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...

The US Food and Drug Administration (FDA) approved or tentatively approved 776 Abbreviated New Drug Applications (ANDAs) for generic drugs in 2021, continuing a steady decline in generic approvals in ...

The availability of generic drugs is expected to have a positive impact in Canada, including potential cost savings for ...

Pfizer has reached agreements with Dexcel Pharma, Hikma Pharmaceuticals and Cipla, regarding lawsuits filed in the U.S.

The Dr. Reddy's medication is the first generic semaglutide authorized by Health Canada. Health Canada noted that it completed the review of Dr. Reddy's submission within its target timeline of 180 ...

New legislation would authorize pharmacists to substitute a biosimilar when filling a prescription, just like a generic, provided your doctor agrees.

Here’s why the case matters: As soon as a generic version of a brand-name drug comes to market, its price typically drops by half. Within 10 years, by more than 75%. Meaning: the sooner we have access ...